drugset / Trial / NCT05504265

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

NCT05504265

RandomizedParallel-groupOpen-labelTreatment

Summary

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.

Timeline

Start
2022-10-10
Primary completion
2025-09-30
Completion
2025-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject flurbiprofen axetil Other / unclassified 50 mg

Indications